Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO
JAMA Ophthalmology Author Interviews
English - October 18, 2018 15:00 - 16 minutes - 15.6 MB - ★★★★ - 5 ratingsMedicine Health & Fitness Science ophthalmology eyes jamanetwork vision Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Interview with Ian Leslie. Mcallister, FRANZCO, author of Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial